|
US6743631B1
|
|
Use of human serum resistant vector particles and cell lines for human gene therapy
|
|
US5854254A
|
|
Male contraceptives
|
|
US5871917A
|
|
Identification of differentially methylated and mutated nucleic acids
|
|
CA2216752A1
|
|
Cartilage repair unit
|
|
US5700289A
|
|
Tissue-engineered bone repair using cultured periosteal cells
|
|
US5548218A
|
|
Flexible RF coils for MRI system
|
|
WO9513290A1
|
|
Method of treating muscular dystrophy
|
|
US5994086A
|
|
Method for assessing infertility by binding of mannose to sperm cells
|
|
WO9319772A1
|
|
A novel therapy for treating sepsis using a soluble form of recombinant cd14 myelomonocytic antigen
|
|
AU3235293A
|
|
Method of reducing medical device related infections
|
|
WO9304168A1
|
|
Transgenic non-human animal model for developing and testing therapies to treat sepsis
|
|
US6200747B1
|
|
Method and kits for detection of fragile X specific, GC-rich DNA sequences
|
|
US4709332A
|
|
High speed image data processing
|
